Genetic Immunization with CDR3-Based Fusion Vaccine Confers Protection and Long-Term Tumor-Free Survival in a Mouse Model of Lymphoma

Table 1

Reactivity of mouse sera against a CDR3 control (irrelevant) peptide as assessed by ELISA.

Mice groups	Vaccine formulation	Absorbance (nm)^1	𝑃^2AversusB
A	pTTVHCDR3	0.159±0.161	NS
B	pTT	0.049±0.208

¹ Control values belonging to unimmunized mice were subtracted.
² Unpaired, two-tailed t-test.
NS: not significant.